|
|
--- |
|
|
license: mit |
|
|
language: |
|
|
- en |
|
|
tags: |
|
|
- clinical_trial |
|
|
size_categories: |
|
|
- 1M<n<10M |
|
|
--- |
|
|
|
|
|
# TrialAlign |
|
|
<p align="center"> |
|
|
π€ <a href="https://huggingface.co/linjc16/Panacea-7B-Chat" target="_blank">[Panacea Model] </a> β’ π» <a href="https://github.com/linjc16/Panacea" target="_blank">[Github Repo]</a> β’ π <a href="https://arxiv.org/pdf/2407.11007" target="_blank">[Panacea Paper]</a> |
|
|
</p> |
|
|
|
|
|
TrialAlign datasets are the continual pretraining corpus for "Panacea: A foundation model for clinical trial search, summarization, design, and recruitment". TrialAlign contains 793,279 clinical trial design documents worldwide and 1,113,207 clinical study papers. |
|
|
|
|
|
## Load the dataset |
|
|
```bash |
|
|
pip install -U datasets fsspec |
|
|
``` |
|
|
|
|
|
```python |
|
|
from datasets import load_dataset |
|
|
ds = load_dataset('linjc16/ctgov', split='train') |
|
|
``` |
|
|
|
|
|
## Statistics of TrialAlign |
|
|
|
|
|
| Source | Counts | |
|
|
|---------------------------------|----------| |
|
|
| ClinicalTrials.gov | 432,676 | |
|
|
| ChiCTR (China) | 65,181 | |
|
|
| EUCTR (EU) | 43,315 | |
|
|
| JRCT (Japan) | 60,645 | |
|
|
| ANZCTR (Australia/New Zealand) | 23,374 | |
|
|
| ISRCTN.org | 22,966 | |
|
|
| ReBEC (Brazil) | 5,889 | |
|
|
| CRIS (Korea) | 8,428 | |
|
|
| DRKS (Germany) | 13,789 | |
|
|
| IRCT (Iran) | 34,097 | |
|
|
| TCTR (Thailand) | 7,443 | |
|
|
| LTR (Netherlands) | 9,768 | |
|
|
| PACTR (Africa) | 3,848 | |
|
|
| SLCTR (Sri Lanka) | 421 | |
|
|
| Trial Papers (Embase + PubMed) | 1,113,207| |
|
|
|
|
|
|
|
|
|
|
|
## Citation |
|
|
|
|
|
If you find our work useful, please consider citing Panacea: |
|
|
|
|
|
``` |
|
|
@article{lin2024panacea, |
|
|
title={Panacea: A foundation model for clinical trial search, summarization, design, and recruitment}, |
|
|
author={Lin, Jiacheng and Xu, Hanwen and Wang, Zifeng and Wang, Sheng and Sun, Jimeng}, |
|
|
journal={arXiv preprint arXiv:2407.11007}, |
|
|
year={2024} |
|
|
} |
|
|
``` |